Comparing the population of tumour associated immune cells at 7 and 14 days after TC-1 tumour inoculation, we observed a significantly higher proportion of CD45+ cells at 7 days compared with 14 days (18.5% versus 11.0%: p < 0.0001) (Figure 5A and Table S3). The gene discussed is PTPRC; the disease is neoplasm.